
General Oncology
Massachusetts-based General Oncology develops treatments for metastatic cancers, currently conducting a clinical trial for BRCA-related pancreatic cancer.
- 7
- Private company
- Brookline, MA, USUnited States
General Oncology is a biopharmaceutical company developing drug candidates designed to overcome tumor drug resistance while minimizing chronic toxicity. Its programs focus on metastatic cancers and other proliferative diseases with high unmet medical need, where current therapies provide limited durable benefit.
GO-4 is designed to treat metastatic cancers, including pancreatic cancer. GO-2301 is a novel drug candidate being developed for proliferative diseases including wet age-related macular degeneration and diabetic retinopathy.
Similar Companies

GO Therapeutics
gotherapeutics.com

ImageneBio
imagenebio.com

G1 Therapeutics
g1therapeutics.com

OncoTartis

Clovis Oncology
clovisoncology.com

Revolution Medicines
revmed.com

Oncotelic Therapeutics
oncotelic.com

Oncology Honduras

Coare Biotechnology

D2G Oncology
d2g-oncology.com

Cullinan Oncology

OncoPrecision
oncoprecision.bio

Western Oncolytics

Vanquish Oncology

OncoSpherix
oncospherix.com

Oncternal Therapeutics
oncternal.com

Champions Oncology

AOA Dx
aoadx.com

OnCusp Therapeutics
oncusptx.com

Vivacitas Oncology
vivaoncology.com
Quick Facts
Who are General Oncology's competitors?
Companies similar to General Oncology include GO Therapeutics, ImageneBio, G1 Therapeutics and OncoTartis.
When was General Oncology founded?
General Oncology was founded in 2015.
Where is General Oncology's headquarters located?
General Oncology's headquarters is located in Brookline, MA, US.
When was General Oncology's last funding round?
General Oncology's most recent funding round was for $6M (USD) in June 2019.
How much disclosed funding has General Oncology raised?
As of Jun 25, 2019, General Oncology has disclosed funding of $6M (USD). Undisclosed round amounts are excluded.
How many employees does General Oncology have?
General Oncology has 7 employees as of Feb 5, 2024.
Classification
- Industry
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Also Known As
- General Oncology, Inc.
- Headquarters
- 202 Washington Street
- Suite 318
- Brookline, MA, 02445
- US
- SEC CIK
- 0001658021
- NAICS
- 620000Health Care and Social Assistance
- SIC
- 8000Health Services
- 8040Offices And Clinics Of Other Health Practitioners
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
- Industry
- —Health Care Companies
- —Medical Organizations
- —Public Health Organizations
Show 7 more industry codes
- NAICS
- 621000Ambulatory Health Care Services
- 621400Outpatient Care Centers
- 621490Other Outpatient Care Centers
- 621491HMO Medical Centers
- 623000Nursing and Residential Care Facilities
- SIC
- 8010Offices And Clinics Of Doctors Of Medicine
- 8011Offices And Clinics Of Doctors Of Medicine